[
    [
        {
            "time": "",
            "original_text": "人福医药“归核化”成效不佳？",
            "features": {
                "keywords": [
                    "人福医药",
                    "归核化",
                    "成效不佳"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "人福医药“归核化”成效不佳？",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "医保谈判结果出炉后，市场反应如何？",
            "features": {
                "keywords": [
                    "医保谈判",
                    "结果",
                    "市场反应"
                ],
                "sentiment_score": 0.2,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医保谈判结果出炉后，市场反应如何？",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "74种药品“晋级”国家医保目录，多家上市公司产品榜上有名",
            "features": {
                "keywords": [
                    "药品",
                    "晋级",
                    "国家医保目录",
                    "上市公司"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "74种药品“晋级”国家医保目录，多家上市公司产品榜上有名",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 9,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "医保谈判平均降价61.71%，多个罕见病药物进入医保",
            "features": {
                "keywords": [
                    "医保谈判",
                    "降价",
                    "罕见病药物",
                    "进入医保"
                ],
                "sentiment_score": 0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医保谈判平均降价61.71%，多个罕见病药物进入医保",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 6,
                "Market_Scope": 10,
                "Time_Proximity": 10,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "医保谈判平均降价61.71% 多个罕见病药物进入医保",
            "features": {
                "keywords": [
                    "医保谈判",
                    "降价",
                    "罕见病药物",
                    "进入医保"
                ],
                "sentiment_score": 0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医保谈判平均降价61.71% 多个罕见病药物进入医保",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 6,
                "Market_Scope": 10,
                "Time_Proximity": 10,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        }
    ]
]